Bayer Pharmaceuticals and Zydus Lifesciences revealed that their collaborative enterprise, Bayer Zydus Pharma Private Limited (BZPPL), reached a successful completion. Bayer is set to acquire the remaining twenty-five percent share of the joint venture for ₹282 crore.
The partnership, which was equally owned by both firms since its establishment on January 28, 2011, focused on the sales and marketing of pharmaceutical products across India. Bayer will now take complete control of the venture following the pre-established terms of the joint venture agreement.
As reported by the Financial Express, the collaboration effectively combines Zydus’s extensive marketing, sales capabilities, and distribution network in India with Bayer’s global prowess in launching innovative products and introducing new advancements in the Indian market.
